Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Association between Heat Exposure and Hospitalization for Diabetes in Brazil during 2000-2015: A Nationwide Case-Crossover Study.

Xu R, Zhao Q, Coelho MSZS, Saldiva PHN, Zoungas S, Huxley RR, Abramson MJ, Guo Y, Li S.

Environ Health Perspect. 2019 Nov;127(11):117005. doi: 10.1289/EHP5688. Epub 2019 Nov 20.

2.

Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial.

Ohkuma T, Zoungas S, Jun M, Lisheng L, Mancia G, Marre M, Rodgers A, Williams B, Woodward M, Chalmers J; ADVANCE Collaborative Group.

Diabetes Obes Metab. 2019 Sep 4. doi: 10.1111/dom.13878. [Epub ahead of print]

PMID:
31486188
3.

The modulating effect of differences in cardiovascular risk factors on major cardiovascular outcomes in glucose-lowering trials: 'good to know' but not the whole story.

Gasevic D, Zoungas S.

J Hypertens. 2019 Oct;37(10):1959-1960. doi: 10.1097/HJH.0000000000002181. No abstract available.

PMID:
31464860
4.

Association between Dietary Intake and Lipid-Lowering Therapy: Prospective Analysis of Data from Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Using a Quantile Regression Approach.

Gadowski AM, Nanayakkara N, Heritier S, Magliano DJ, Shaw JE, Curtis AJ, Zoungas S, Owen AJ.

Nutrients. 2019 Aug 9;11(8). pii: E1858. doi: 10.3390/nu11081858.

5.

Outcomes of people with severe hypoglycaemia requiring prehospital emergency medical services management: a prospective study.

Villani M, Earnest A, Smith K, Giannopoulos D, Soldatos G, de Courten B, Zoungas S.

Diabetologia. 2019 Oct;62(10):1868-1879. doi: 10.1007/s00125-019-4933-y. Epub 2019 Jul 15.

PMID:
31309262
6.

The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study.

Zimbudzi E, Lo C, Robinson T, Ranasinha S, Teede HJ, Usherwood T, Polkinghorne KR, Kerr PG, Fulcher G, Gallagher M, Jan S, Cass A, Walker R, Russell G, Johnson G, Zoungas S.

PLoS One. 2019 Jul 15;14(7):e0219685. doi: 10.1371/journal.pone.0219685. eCollection 2019.

7.

Changes in plasma lipids predict pravastatin efficacy in secondary prevention.

Jayawardana KS, Mundra PA, Giles C, Barlow CK, Nestel PJ, Barnes EH, Kirby A, Thompson P, Sullivan DR, Alshehry ZH, Mellett NA, Huynh K, McConville MJ, Zoungas S, Hillis GS, Chalmers J, Woodward M, Marschner IC, Wong G, Kingwell BA, Simes J, Tonkin AM, Meikle PJ; LIPID Study Investigators.

JCI Insight. 2019 Jul 11;4(13). pii: 128438. doi: 10.1172/jci.insight.128438. eCollection 2019 Jul 11.

8.

Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome.

Ofori-Asenso R, Zomer E, Chin KL, Markey P, Si S, Ademi Z, Curtis AJ, Zoungas S, Liew D.

Cardiovasc Diagn Ther. 2019 Jun;9(3):250-261. doi: 10.21037/cdt.2019.04.06.

9.

Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.

Ohkuma T, Jun M, Chalmers J, Cooper ME, Hamet P, Harrap S, Zoungas S, Perkovic V, Woodward M; ADVANCE Collaborative Group.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):862-872. doi: 10.2215/CJN.13391118. Epub 2019 Jun 3.

PMID:
31160317
10.

A need-based approach to self-management education for adults with co-morbid diabetes and chronic kidney disease.

Zimbudzi E, Lo C, Kerr PG, Zoungas S.

BMC Nephrol. 2019 Apr 2;20(1):113. doi: 10.1186/s12882-019-1296-z.

11.

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.

International Hypoglycaemia Study Group.

Lancet Diabetes Endocrinol. 2019 May;7(5):385-396. doi: 10.1016/S2213-8587(18)30315-2. Epub 2019 Mar 27. Review. Erratum in: Lancet Diabetes Endocrinol. 2019 Jun;7(6):e18.

12.

Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes.

Chin KL, Ofori-Asenso R, Si S, Hird TR, Magliano DJ, Zoungas S, Liew D.

Sci Rep. 2019 Mar 1;9(1):3256. doi: 10.1038/s41598-019-40191-8.

13.

The Effects of Statins on Physical Activity or Physical Fitness Among Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Gadowski A, Owen AJ, Curtis A, Nanayakkara N, Heritier S, Misso M, Zoungas S.

J Aging Phys Act. 2019 Jun 6:1-13. doi: 10.1123/japa.2018-0305. [Epub ahead of print]

PMID:
30747563
14.

Reply to: Statins for Primary Prevention in Older Adults.

Singh S, Go AS, Wenger NK, Zoungas S, Gurwitz JH.

J Am Geriatr Soc. 2019 Apr;67(4):857-858. doi: 10.1111/jgs.15762. Epub 2019 Jan 28. No abstract available.

PMID:
30688359
15.

Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede HJ, Kerr PG, Ranasinha S, Cass A, Fulcher G, Gallagher M, Polkinghorne KR, Russell G, Usherwood T, Walker R, Zoungas S.

J Diabetes Complications. 2019 Jan;33(1):63-68. doi: 10.1016/j.jdiacomp.2018.09.020. Epub 2018 Oct 12.

PMID:
30621853
16.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

17.

Patterns of Medication Dispensation for Multiple Comorbidities among Older Adults in Australia.

Ofori-Asenso R, Ilomaki J, Curtis AJ, Zomer E, Zoungas S, Liew D.

Pharmacy (Basel). 2018 Dec 17;6(4). pii: E134. doi: 10.3390/pharmacy6040134.

18.

Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies.

Chin KL, Ofori-Asenso R, Hopper I, von Lueder TG, Reid CM, Zoungas S, Wang BH, Liew D.

Cardiovasc Res. 2019 Feb 1;115(2):266-276. doi: 10.1093/cvr/cvy295.

PMID:
30475996
19.

Switching, Discontinuation, and Reinitiation of Statins Among Older Adults.

Ofori-Asenso R, Ilomaki J, Tacey M, Zomer E, Curtis AJ, Si S, Zullo AR, Korhonen MJ, Bell JS, Zoungas S, Liew D.

J Am Coll Cardiol. 2018 Nov 27;72(21):2675-2677. doi: 10.1016/j.jacc.2018.08.2191. No abstract available.

20.

Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease.

Zimbudzi E, Lo C, Ranasinha S, Fulcher G, Gallagher M, Jan S, Kerr PG, Teede HJ, Polkinghorne KR, Russell G, Walker RG, Zoungas S.

Health Qual Life Outcomes. 2018 Nov 19;16(1):215. doi: 10.1186/s12955-018-1044-2.

21.

Predictors of statin use among older adults: A nationwide cross-sectional study.

Ofori-Asenso R, Ilomäki J, Tacey M, Zomer E, Curtis AJ, Bell JS, Zoungas S, Liew D.

J Clin Lipidol. 2019 Jan - Feb;13(1):156-162.e1. doi: 10.1016/j.jacl.2018.10.002. Epub 2018 Oct 16.

PMID:
30446321
22.

Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute Stroke.

Ofori-Asenso R, Zomer E, Chin KL, Si S, Markey P, Tacey M, Curtis AJ, Zoungas S, Liew D.

Int J Environ Res Public Health. 2018 Nov 12;15(11). pii: E2532. doi: 10.3390/ijerph15112532.

23.

Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.

Ofori-Asenso R, Ilomäki J, Tacey M, Si S, Curtis AJ, Zomer E, Bell JS, Zoungas S, Liew D.

Br J Clin Pharmacol. 2019 Jan;85(1):227-235. doi: 10.1111/bcp.13797. Epub 2018 Nov 8.

PMID:
30402916
24.

Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making.

Singh S, Zieman S, Go AS, Fortmann SP, Wenger NK, Fleg JL, Radziszewska B, Stone NJ, Zoungas S, Gurwitz JH.

J Am Geriatr Soc. 2018 Nov;66(11):2188-2196. doi: 10.1111/jgs.15449. Epub 2018 Oct 2. Review.

25.

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M, Cass A, Hawley CM, Pilmore H, Badve SV, Perkovic V, Zoungas S.

Cochrane Database Syst Rev. 2018 Sep 24;9:CD011798. doi: 10.1002/14651858.CD011798.pub2. Review.

26.

Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention.

Mundra PA, Barlow CK, Nestel PJ, Barnes EH, Kirby A, Thompson P, Sullivan DR, Alshehry ZH, Mellett NA, Huynh K, Jayawardana KS, Giles C, McConville MJ, Zoungas S, Hillis GS, Chalmers J, Woodward M, Wong G, Kingwell BA, Simes J, Tonkin AM, Meikle PJ; LIPID Study Investigators.

JCI Insight. 2018 Sep 6;3(17). pii: 121326. doi: 10.1172/jci.insight.121326. eCollection 2018 Sep 6.

27.

Age-related differences in glycaemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: a cross-sectional study from the Australian National Diabetes Audit.

Nanayakkara N, Ranasinha S, Gadowski AM, Davis WA, Flack JR, Wischer N, Andrikopoulos S, Zoungas S.

BMJ Open. 2018 Aug 17;8(8):e020677. doi: 10.1136/bmjopen-2017-020677.

28.

Recent Patterns of Multimorbidity Among Older Adults in High-Income Countries.

Ofori-Asenso R, Chin KL, Curtis AJ, Zomer E, Zoungas S, Liew D.

Popul Health Manag. 2019 Apr;22(2):127-137. doi: 10.1089/pop.2018.0069. Epub 2018 Aug 10.

PMID:
30096023
29.

Comparing two methods for delivering clinical trial informed consent information to older adults: singular versus stepped approach.

O'Hare F, Flanagan Z, Nelson M, Curtis A, Heritier S, Spark S, Zoungas S.

Clin Trials. 2018 Dec;15(6):610-615. doi: 10.1177/1740774518793377. Epub 2018 Aug 3.

PMID:
30074410
30.

LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk.

Ofori-Asenso R, Zoungas S, Tonkin A, Liew D.

Clin Pharmacol Ther. 2018 Aug;104(2):235-238. doi: 10.1002/cpt.1125. Epub 2018 Jul 13. No abstract available.

PMID:
30004113
31.

Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial.

O'Hare F, Spark S, Flanagan Z, Heritier S, Curtis A, Zoungas S; STAREE Investigator Group.

Contemp Clin Trials Commun. 2018 Jun 12;11:89-94. doi: 10.1016/j.conctc.2018.05.003. eCollection 2018 Sep.

32.

Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia.

Ofori-Asenso R, Ilomaki J, Tacey M, Curtis AJ, Zomer E, Bell JS, Zoungas S, Liew D.

Am J Alzheimers Dis Other Demen. 2018 Dec;33(8):527-534. doi: 10.1177/1533317518787314. Epub 2018 Jul 10.

PMID:
29991271
33.

Risk-adjustment of diabetes health outcomes improves the accuracy of performance benchmarking.

Danek E, Earnest A, Wischer N, Andrikopoulos S, Pease A, Nanayakkara N, Zoungas S.

Sci Rep. 2018 Jul 6;8(1):10261. doi: 10.1038/s41598-018-28101-w.

34.

Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial.

Thomas MC, Woodward M, Li Q, Pickering R, Tikellis C, Poulter N, Cooper ME, Marre M, Zoungas S, Chalmers J; ADVANCE Collaborative Group.

J Am Heart Assoc. 2018 Jun 30;7(13). pii: e008226. doi: 10.1161/JAHA.117.008226.

35.

Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysis.

Zimbudzi E, Lo C, Misso ML, Ranasinha S, Kerr PG, Teede HJ, Zoungas S.

Syst Rev. 2018 Jun 13;7(1):84. doi: 10.1186/s13643-018-0748-z.

36.

Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).

Pease A, Earnest A, Ranasinha S, Nanayakkara N, Liew D, Wischer N, Andrikopoulos S, Zoungas S.

Cardiovasc Diabetol. 2018 Jun 2;17(1):77. doi: 10.1186/s12933-018-0726-8.

37.

A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data.

Ofori-Asenso R, Ilomäki J, Zomer E, Curtis AJ, Zoungas S, Liew D.

Cardiovasc Drugs Ther. 2018 Jun;32(3):265-272. doi: 10.1007/s10557-018-6794-x.

PMID:
29790056
38.

A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks.

Riddle MC, Gerstein HC, Holman RR, Inzucchi SE, Zinman B, Zoungas S, Cefalu WT.

Diabetes Care. 2018 Jun;41(6):1121-1124. doi: 10.2337/dci18-0018. No abstract available.

PMID:
29784695
39.

Depression and diabetes distress in adults with type 2 diabetes: results from the Australian National Diabetes Audit (ANDA) 2016.

Nanayakkara N, Pease A, Ranasinha S, Wischer N, Andrikopoulos S, Speight J, de Courten B, Zoungas S.

Sci Rep. 2018 May 18;8(1):7846. doi: 10.1038/s41598-018-26138-5.

40.

Real-time continuous glucose monitoring improves glycaemic variability and neonatal outcomes in pregnant women with type 1 diabetes.

Abell SK, Zoungas S.

BMJ Evid Based Med. 2018 May 15. pii: bmjebm-2018-110927. doi: 10.1136/bmjebm-2018-110927. [Epub ahead of print] Review. No abstract available.

PMID:
29764813
41.

Reinitiation of Statin Therapy After Discontinuation: A Meta-analysis.

Ofori-Asenso R, Zoungas S, Liew D.

Mayo Clin Proc. 2018 May;93(5):666-668. doi: 10.1016/j.mayocp.2018.01.011. No abstract available. Erratum in: Mayo Clin Proc. 2018 Jul;93(7):960.

PMID:
29728206
42.

Patterns of statin use and long-term adherence and persistence among older adults with diabetes.

Ofori-Asenso R, Ilomäki J, Tacey M, Zomer E, Curtis AJ, Bell JS, Zoungas S, Liew D.

J Diabetes. 2018 Sep;10(9):699-707. doi: 10.1111/1753-0407.12769. Epub 2018 May 10.

PMID:
29658177
43.

Geographical variation of diabetic emergencies attended by prehospital Emergency Medical Services is associated with measures of ethnicity and socioeconomic status.

Villani M, Earnest A, Smith K, de Courten B, Zoungas S.

Sci Rep. 2018 Mar 23;8(1):5122. doi: 10.1038/s41598-018-23457-5.

44.

Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review.

Pease A, Lo C, Earnest A, Liew D, Zoungas S.

Syst Rev. 2018 Mar 12;7(1):44. doi: 10.1186/s13643-018-0706-9. Review.

45.

Do sulphonylureas still have a place in clinical practice?

Khunti K, Chatterjee S, Gerstein HC, Zoungas S, Davies MJ.

Lancet Diabetes Endocrinol. 2018 Oct;6(10):821-832. doi: 10.1016/S2213-8587(18)30025-1. Epub 2018 Feb 28. Review.

PMID:
29501322
46.

Models of care for co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede H, Cass A, Fulcher G, Gallagher M, Kerr PG, Jan S, Johnson G, Mathew T, Polkinghorne K, Russell G, Usherwood T, Walker R, Zoungas S.

Nephrology (Carlton). 2018 Aug;23(8):711-717. doi: 10.1111/nep.13232. Review.

PMID:
29405503
47.

A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years.

Ofori-Asenso R, Jakhu A, Curtis AJ, Zomer E, Gambhir M, Jaana Korhonen M, Nelson M, Tonkin A, Liew D, Zoungas S.

J Gerontol A Biol Sci Med Sci. 2018 May 9;73(6):798-805. doi: 10.1093/gerona/glx256.

PMID:
29360935
48.

Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes.

Nanayakkara N, Ranasinha S, Gadowski A, Heritier S, Flack JR, Wischer N, Wong J, Zoungas S.

J Diabetes Complications. 2018 Mar;32(3):279-290. doi: 10.1016/j.jdiacomp.2017.11.009. Epub 2017 Dec 7.

PMID:
29352694
49.

Intensive glucose control in patients with diabetes prevents onset and progression of microalbuminuria, but effects on end-stage kidney disease are still uncertain.

Lo C, Zoungas S.

Evid Based Med. 2017 Dec;22(6):219-220. doi: 10.1136/ebmed-2017-110806. Epub 2017 Nov 2. Review. No abstract available.

PMID:
29097446
50.

Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.

Jun M, Ohkuma T, Zoungas S, Colagiuri S, Mancia G, Marre M, Matthews D, Poulter N, Williams B, Rodgers A, Perkovic V, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Diabetes Care. 2018 Jan;41(1):163-170. doi: 10.2337/dc17-1467. Epub 2017 Oct 27.

PMID:
29079715

Supplemental Content

Loading ...
Support Center